Related references
Note: Only part of the references are listed.Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
Ann-Lii Cheng et al.
JOURNAL OF HEPATOLOGY (2022)
Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trail)
Tadatoshi Takayama et al.
LIVER CANCER (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial
Elisabeth Dhondt et al.
RADIOLOGY (2022)
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
Tae Hyun Kim et al.
JOURNAL OF HEPATOLOGY (2021)
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
Riad Salem et al.
HEPATOLOGY (2021)
Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study
R. Troisi et al.
BRITISH JOURNAL OF SURGERY (2021)
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis
Giammauro Berardi et al.
JOURNAL OF HEPATOLOGY (2020)
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study
Masatoshi Kudo et al.
CANCERS (2019)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes
Neil Mehta et al.
HEPATOLOGY (2019)
Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study
Neil Mehta et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
Riad Salem et al.
HEPATOLOGY (2018)
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
Jean-Charles Nault et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC
Arnaud Hocquelet et al.
JOURNAL OF HEPATOLOGY (2017)
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
Gonzalo Sapisochin et al.
JOURNAL OF HEPATOLOGY (2017)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
David J. Pinato et al.
JOURNAL OF HEPATOLOGY (2017)
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series
Olivier Sutter et al.
RADIOLOGY (2017)
Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis A Propensity Score Matched Analysis
Young-In Yoon et al.
ANNALS OF SURGERY (2017)
Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma
C. Sposito et al.
BRITISH JOURNAL OF SURGERY (2016)
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results
Olivier Seror et al.
RADIOLOGY (2016)
A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90
Jin-Yao Teo et al.
HPB (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
Francis Y. Yao et al.
HEPATOLOGY (2015)
Portal Hypertension and the Outcome of Surgery for Hepatocellular Carcinoma in Compensated Cirrhosis: A Systematic Review and Meta-analysis
Annalisa Berzigotti et al.
HEPATOLOGY (2015)
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
Neehar D. Parikh et al.
LIVER TRANSPLANTATION (2015)
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
Alessandro Cucchetti et al.
JOURNAL OF HEPATOLOGY (2013)
Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection
Michael Vouche et al.
JOURNAL OF HEPATOLOGY (2013)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention-to-treat analysis
David Fuks et al.
HEPATOLOGY (2012)
Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis
Gisele N'Kontchou et al.
JOURNAL OF HEPATOLOGY (2012)
Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2011)
Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation
Bruno Sangro et al.
HEPATOLOGY (2011)
Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival
Philip Hilgard et al.
HEPATOLOGY (2010)
Safety and efficacy of Y-90 radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura M. Kulik et al.
HEPATOLOGY (2008)
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
Tito Livraghi et al.
HEPATOLOGY (2008)
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
S Shiina et al.
GASTROENTEROLOGY (2005)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Share Paper
